Using of virtual chinese population for ethnic sensitivity assessment in drug development: introduction of roche
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: SHI, Jun (Shanghai, China)
- Co-author(s): Hu (Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical Colleg, Beijing, China)
In recent years, there has been a dramatic increase in the number of global clinical trials. This trend offers opportunities of cost saving and recruitment acceleration to the US/EU, and minimizing duplication of clinical data and shortening the drug approval gap to China. To ensure its success, ethnic sensitivity in drug response prior to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.